IRhythm Operating Cycle from 2010 to 2026
| IRTC Stock | USD 133.76 6.42 4.58% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 72.89577508 | Current Value 91.73 | Quarterly Volatility 21.16694897 |
Check IRhythm Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRhythm Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.8 M, Total Revenue of 784.5 M or Gross Profit of 553.6 M, as well as many indicators such as Price To Sales Ratio of 10.69, Dividend Yield of 0.0 or PTB Ratio of 39.04. IRhythm financial statements analysis is a perfect complement when working with IRhythm Technologies Valuation or Volatility modules.
IRhythm | Operating Cycle | Build AI portfolio with IRhythm Stock |
Analyzing IRhythm Technologies's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing IRhythm Technologies's current valuation and future prospects.
Latest IRhythm Technologies' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of iRhythm Technologies over the last few years. It is IRhythm Technologies' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRhythm Technologies' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
IRhythm Operating Cycle Regression Statistics
| Arithmetic Mean | 90.07 | |
| Geometric Mean | 87.88 | |
| Coefficient Of Variation | 23.50 | |
| Mean Deviation | 17.82 | |
| Median | 84.76 | |
| Standard Deviation | 21.17 | |
| Sample Variance | 448.04 | |
| Range | 57.972 | |
| R-Value | (0.68) | |
| Mean Square Error | 259.40 | |
| R-Squared | 0.46 | |
| Significance | 0 | |
| Slope | (2.83) | |
| Total Sum of Squares | 7,169 |
IRhythm Operating Cycle History
About IRhythm Technologies Financial Statements
IRhythm Technologies stakeholders use historical fundamental indicators, such as IRhythm Technologies' Operating Cycle, to determine how well the company is positioned to perform in the future. Although IRhythm Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in IRhythm Technologies' assets and liabilities are reflected in the revenues and expenses on IRhythm Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in iRhythm Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 72.90 | 91.73 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:Check out the analysis of IRhythm Technologies Correlation against competitors. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Health Care Equipment & Supplies sector continue expanding? Could IRhythm diversify its offerings? Factors like these will boost the valuation of IRhythm Technologies. Market participants price IRhythm higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IRhythm Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.62) | Revenue Per Share | Quarterly Revenue Growth 0.271 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, IRhythm Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.